Target site concentrations after continuous infusion and bolus injection of cefpirome to healthy volunteers

被引:36
作者
Hollenstein, U
Brunner, M
Mayer, BX
Delacher, S
Erovic, B
Eichler, HG
Müller, M
机构
[1] Univ Hosp Vienna, Dept Clin Pharmacol, Div Clin Pharmacokinet, Vienna, Austria
[2] Univ Hosp Vienna, Dept Internal Med 1, Div Infect Dis & Chemotherapy, Vienna, Austria
关键词
D O I
10.1067/mcp.2000.104266
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Recent data indicate a higher level of effectivity of beta-lactam antibiotics if serum concentrations are kept above the minimal inhibitory concentration (MIC) of the pathogen. This concept would favor continuous infusion over bolus dosing. However, it is usually not the serum concentration but the free interstitial concentration in the target tissue that determines antibiotic activity. We therefore set out to measure effective drug concentrations in the interstitial space of muscle and subcutaneous adipose tissue and to compare trough levels and times above the MIC after bolus versus continuous infusion of cefpirome. Methods: Twelve healthy volunteers received a single dose of 2 g cefpirome as an intravenous bolus or as a continuous infusion over 8 hours in a crossover design, and the resulting free interstitial tissue concentrations were measured with use of microdialysis. Results: After bolus injection, mean interstitial trough concentrations were 3.0 +/- 1.9 mu g/mL and 2.1 +/- 1.0 mu g/mL for muscle and subcutaneous tissue, respectively; continuous infusion resulted in trough levels of 10.1 +/- 6.8 mu g/mL and 10.1 +/- 4.6 mu g/mL for muscle and subcutaneous tissue, respectively. This resulted in significantly longer times above the MIC with continuous infusion for Straphylococcus epidermidis and Enterobacter cloacae. Bacteria with an MIC less than or equal to 1 would be covered by either method, whereas higher doses seem to be necessary for Pseudomonas aeruginosa. Conclusion: Although susceptible organisms will usually be covered sufficiently with standard dosing regimens, soft tissue infections with bacteria that have MIC values of 2 to 8 may profit from continuous application. Coverage of P aeruginosa, however, would be inadequate with conventional daily doses of 4 g cefpirome regardless of the method of application.
引用
收藏
页码:229 / 236
页数:8
相关论文
共 33 条
[11]   THE IMPORTANCE OF PHARMACOKINETIC-PHARMACODYNAMIC SURROGATE MARKERS TO OUTCOME - FOCUS ON ANTIBACTERIAL AGENTS [J].
HYATT, JM ;
MCKINNON, PS ;
ZIMMER, GS ;
SCHENTAG, JJ .
CLINICAL PHARMACOKINETICS, 1995, 28 (02) :143-160
[12]   EXPERIMENTAL STREPTOCOCCUS-PNEUMONIAE INFECTION IN MICE FOR STUDYING CORRELATION OF IN-VITRO AND IN-VIVO ACTIVITIES OF PENICILLIN AGAINST PNEUMOCOCCI WITH VARIOUS SUSCEPTIBILITIES TO PENICILLIN [J].
KNUDSEN, JD ;
FRIMODTMOLLER, N ;
ESPERSEN, F .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (06) :1253-1258
[13]   INFLUENCE OF BINDING ON PHARMACOLOGIC ACTIVITY OF ANTIBIOTICS [J].
KUNIN, CM ;
CRAIG, WA ;
KORNGUTH, M ;
MONSON, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1973, 226 (NOV26) :214-224
[14]   Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery [J].
Martin, C ;
Cotin, A ;
Giraud, A ;
Beccani-Argème, M ;
Alliot, P ;
Mallet, MN ;
Argème, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1093-1097
[15]  
Mercer-Jones MA, 1998, BRIT J SURG, V85, P385
[16]   EFFECT OF PROTEIN-BINDING ON ANTIBIOTIC-ACTIVITY INVIVO [J].
MERRIKIN, DJ ;
BRIANT, J ;
ROLINSON, GN .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 11 (03) :233-238
[17]  
Mouton JW, 1996, J ANTIMICROB CHEMOTH, V38, P5
[18]   PHARMACOKINETICS OF CEFTAZIDIME IN SERUM AND SUCTION BLISTER FLUID DURING CONTINUOUS AND INTERMITTENT INFUSIONS IN HEALTHY-VOLUNTEERS [J].
MOUTON, JW ;
HORREVORTS, AM ;
MULDER, PGH ;
PRENS, EP ;
MICHEL, MF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2307-2311
[19]   Characterization of partitioning behavior of cephalosporins using microemulsion and micellar electrokinetic chromatography [J].
Mrestani, Y ;
El-Mokdad, N ;
Rüttinger, HH ;
Neubert, R .
ELECTROPHORESIS, 1998, 19 (16-17) :2895-2899
[20]   Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients [J].
Müller, M ;
Brunner, M ;
Hollenstein, U ;
Joukhadar, C ;
Schmid, R ;
Minar, E ;
Ehringer, H ;
Eichler, HG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) :2056-2058